PDF herunterladen
Semin Thromb Hemost 2017; 43(06): 572-580
DOI: 10.1055/s-0037-1599145
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science

Autoren

  • Soundarya Selvam

    1   Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada

  • Paula James

    1   Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada
    2   Department of Medicine, Queen's University, Kingston, Canada
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
05. Mai 2017 (online)

   Lizenzen und Reprints

Abstract

Severe and intractable gastrointestinal bleeding caused by angiodysplasia is a debilitating problem for up to 20% of patients with von Willebrand disease (VWD). Currently, the lack of an optimal treatment for this recurrent problem presents an ongoing challenge for many physicians in their management of affected patients. Over the past few years, studies have pointed to a regulatory role for the hemostatic protein, von Willebrand factor (VWF), in angiogenesis, providing a novel target for the modulation of vessel development. This article will review the clinical implications and molecular pathology of angiodysplasia in VWD.

Keywords

angiodysplasia - gastrointestinal bleeding - Heyde's syndrome - von Willebrand disease - von Willebrand factor